The use of artificial intelligence (AI) and the latest advances in genetics in the IVF process means greater success rates, improved safety and lower treatment costs for our patients. For us, the outcome of treatment is paramount – on the journey to parenthood, every extra percentage point of success counts.
Artificial intelligence and genetics in the treatment of infertility: the new generation of IVF at INVICTA Clinics
At INVICTA Clinics, we are developing new technologies and methods to improve the effectiveness of treatment and make the journey to parenthood easier for our patients. In vitro AIOO® GPS™ is a globally unique solution, developed by the scientific team at the INVICTA Research and Development Centre. The versatility of this technology makes it a true breakthrough in the field of infertility treatment.
In vitro AIOO® GPS™ is based on the knowledge and experience of over 60 experts, as well as a computerised analysis of over 9,000 infertility treatment histories.
The new generation of IVF is superior to standard treatment methods, offering both greater effectiveness in treating infertility and an appropriate level of safety.
AIOO® – Artificial Intelligence Oocytes – is proprietary software developed using artificial intelligence (AI) algorithms. AIOO® assists the doctor in preparing the optimal stimulation protocol and gonadotropin dosage based on information about the patient. This includes data such as AMH levels, age, BMI, test results, health status and treatment history.
The GPS™ test – Genetic Prediction of Stimulation – is the world’s only genetic test that allows you to verify whether genetic factors may influence the course and outcome of hormonal stimulation. With this information, the AIOO® system can select the stimulation dose with even greater precision.
By working together, AIOO® and GPS™ help the doctor to determine more accurately the likely number of mature eggs that can be retrieved as a result of stimulation. This enables the doctor not only to predict the outcome of the stimulation but also to exercise greater control over the safety of the entire in vitro procedure – as the risk of ovarian hyperstimulation in the patient is significantly reduced.
High quality and the maximum number of mature eggs ready for fertilisation, whilst using the lowest possible doses of the medication required for hormonal stimulation.
Reducing the risk of hyperstimulation.
A personalised in vitro treatment programme.
Obtaining mature, good-quality eggs increases the likelihood of successful fertilisation.
If you are looking for a precise approach that will increase your chances of success from the very first round of IVF treatment, then the AIOO® GPS™ IVF treatment will be the best choice.
A 20 per cent increase in treatment success rates through the precise selection of high-quality, mature eggs in the right quantity, ready for fertilisation
A lower risk of complications and side effects for the patient, thanks to a reduction in the dose of drugs required for hormonal stimulation by an average of 10 per cent
Drawing on the knowledge gained from over 22 years’ experience in the treatment of infertility
Reducing overall treatment costs by minimising the need for repeat procedures
Lower treatment costs as part of the procedure, thanks to accurate predictions based on personalised medical data specific to each patient
In vitro AIOO® GPS™ is recommended for all couples who have been assessed as suitable for IVF treatment and are looking for the latest solutions.
All you need to do is book a consultation with our specialist doctor, during which you will find out whether the In vitro AIOO® GPS™ method is suitable for you.
Call our helpline and choose a date that suits you and your partner. Please note that you do not need a referral for this appointment. Our consultant will provide you with all the necessary information, advise you on which documents to bring to the appointment, and give you a questionnaire to complete at home. You can choose between an in-person appointment at one of our six clinics or an online consultation.
Quick diagnosis – swift action. With the support of AIOO® GPS™, your doctor will recommend a course of hormone treatment that will bring you significantly closer to becoming a mother.
You will receive a simulation of the results for several different hormone stimulation regimens. This provides you with comprehensive information on how many eggs can be retrieved in your situation using each treatment regimen.
With In vitro AIOO® GPS™, you can make informed decisions about the number of eggs to use – without unnecessary surpluses or future dilemmas.
Undergoing the Genetic Stimulation Prediction test increases the accuracy of the AIOO® forecast by up to 20 per cent.
Please note:
The GPS™ genetic test is available exclusively at INVICTA Diagnostic Laboratories and is used solely in the in vitro procedures offered at INVICTA Clinics.
Please contact us and we will arrange an in-person or online appointment for you at a time that suits you.
Book an appointment with a specialist at the INVICTA Fertility Clinic by calling +48 (58) 58 58 800 or via the booking form available on our website.
Our consultant will provide you with the necessary information by phone or email to help you prepare for your appointment.
You will receive a set of useful information and a list of diagnostic tests that you need to have carried out so that you can bring the results with you to your appointment with the specialist.
The first step in preparing for the AIOO® GPS™ in vitro procedure is to undergo an AMH test, followed by a Genetic Prediction of Stimulation (GPS™) test.
During your appointment with your consultant, you will find out what your treatment plan will involve, based on the results discussed and your medical history. Your consultant will carry out a treatment simulation and you will discuss the different stimulation options. This will also be the perfect time to ask any questions you may have.
The remaining stages of the process will be carried out in accordance with the established in vitro procedure.
During your first telephone call, our E-Centre advisers will guide you through the process of preparing for your appointment at the INVICTA Clinic. At the Clinic, you will also meet your Patient Care Coordinator, who will support you throughout your treatment and help you complete the necessary paperwork.
You will also meet with your attending doctor, who will provide you with medical support, draw up a comprehensive treatment plan and implement it step by step.
Your treating doctor may refer you for a consultation with a geneticist, immunologist, psychologist or embryologist.
On the day of your in vitro procedure, our entire team will take care of all your needs.
After the procedure, you will stay with us for a few hours in the recovery room. This will give you plenty of time to rest before returning home.
We will stay in regular contact with you to monitor the success of your AIOO® GPS™ IVF treatment.
Our patients’ stories
In the AIOO® GPS™ in vitro procedure, we utilise proprietary solutions in the fields of artificial intelligence and genetics to raise standards in terms of treatment efficacy, safety and comfort.
Your Patient Coordinator will provide you with all the necessary details.
You will need to meet the standard required for starting the in vitro procedure at INVICTA Clinics, supplemented by AMH and GPS™ tests carried out at the INVICTA Diagnostic Laboratory.
In order to undergo the AIOO® GPS™ in vitro procedure, it is essential that all tests are carried out within the certified INVICTA Laboratory system.
AMH (Anti-Müllerian Hormone) is a hormone produced in both women and men. In women, AMH is produced in the follicles of the ovary by the cells surrounding the eggs ready for growth. AMH levels are not influenced by a woman’s menstrual cycle, so they can be tested on any day of the cycle.
Its levels decrease as a woman ages, making it a very good marker of declining fertility, including premature ovarian failure. Conversely, in patients with PCOS (Polycystic Ovary Syndrome), AMH levels are significantly elevated.
INHIBIN B is used to assess ovarian reserve. Inhibin B is produced by the granulosa cells of early antral follicles. Its concentration in the early follicular phase reflects the number and quality of ovarian follicles. There is a positive correlation between Inhibin B concentrations and the number of antral follicles assessed by ultrasound in the early days of the menstrual cycle.
The use of artificial intelligence to optimise the in vitro treatment process at the INVICTA Clinic is completely safe. AI assists doctors in analysing medical data and making clinical decisions, which eliminates potential human error and improves the quality of patient care.
In vitro treatment using artificial intelligence and genetics is an innovative approach in reproductive medicine, which is available in Poland exclusively at the INVICTA Clinic. Those seeking support in fulfilling their dream of parenthood can be confident that at the INVICTA Clinic they have access to a unique, effective and safe treatment option.
Of course. We warmly welcome patients not only from Poland, but also from abroad.
